Novo holding company buys Norwegian Xellia
COPENHAGEN, May 21 (Reuters) - Novo A/S, the holding company of Danish insulin producer Novo Nordisk, on Tuesday said it had acquired Norwegian-based Xellia Pharmaceuticals for about $700 million. The company has been bought from 3i and other shareholders, and Xellia will revert to Danish o
Read more